한글목차

세계의 원료의약품(API) 시장 규모는 2033년까지 6.7%의 CAGR로 성장할 것으로 예측되고 있습니다. 제네릭 의약품의 수요 증가, 신흥 국가에서 중간 소득층의 증가는 시장의 성장을 촉진하고 있습니다.

세계의 원료의약품(API) 시장에 대해 조사했으며, 시장 개요, 시장 분석, 기업 개요 등의 정보를 제공하고 있습니다.

목차

제1장 리포트의 개요

제2장 주요 요약

제3장 시장 개요

• 주요 조사 결과
• 시장 역학
• 촉진요인
• 억제요인
• 시장 기회
• COVID-19의 영향 분석
• Porter's Five Forces 분석
  • 공급 기업의 교섭력
  • 구매자의 교섭력
  • 경쟁 기업간 경쟁 관계
  • 대체품의 위협
  • 신규 진출업체의 위협
• PEST 분석

제4장 원료의약품(API) 시장 분석 : 치료 용도별

• 주요 조사 결과
• 치료 용도 부문 : 시장 매력 지수
• 원료의약품(API) 시장 규모 추정과 예측 : 치료 용도별
• 종양
• 항당뇨병약
• 호흡기
• 면역억제제
• 신경 내과
• 심장병
• 안과
• 정형외과
• 기타

제5장 원료의약품(API) 시장 분석 : 합성 유형별

• 주요 조사 결과
• 합성 유형 부문 : 시장 매력 지수
• 원료의약품(API) 시장 규모 추정과 예측 : 합성 유형별
• 합성
• 바이오테크놀러지

제6장 원료의약품(API) 시장 분석 : 제조업체별

• 주요 조사 결과
• 제조업체 부문 : 시장 매력 지수
• 원료의약품(API) 시장 규모 추정과 예측 : 제조업체별
• 머천트 API
• 캡티브 API

제7장 원료의약품(API) 시장 분석 : 의약품 유형별

• 주요 조사 결과
• 의약품 유형 부문 : 시장 매력 지수
• 원료의약품(API) 시장 규모 추정과 예측 : 의약품 유형별
• 브랜드
• 제네릭

제8장 원료의약품(API) 시장 분석 : 지역별

• 주요 조사 결과
• 지역 시장 규모 추정과 예측

제9장 북미의 원료의약품(API) 시장 분석

제10장 유럽의 원료의약품(API) 시장 분석

제11장 아시아태평양의 원료의약품(API) 시장 분석

제12장 라틴아메리카의 원료의약품(API) 시장 분석

제13장 중동 및 아프리카의 원료의약품(API) 시장 분석

제14장 기업 개요

• 경쟁 구도(2022년)
• 전략 전망
• Aarti Drugs Ltd.
• Aurobindo Pharma
• Biocon
• Cipla Inc.
• Divi's Laboratories Limited
• Dr. Reddy's Laboratories Ltd.
• EUROAPI
• HIKAL Ltd.
• Merck &Co., Inc.
• Teva Pharmaceutical Industries Ltd.

제15장 결론과 권장사항

• 결론
• 시장 참여 기업에 대한 권장사항

영문목차

The global Active Pharmaceutical Ingredients (APIs) is projected to grow at a CAGR of 6.7% by 2033.

“The Active Pharmaceutical Ingredients (APIs) Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Active Pharmaceutical Ingredients Market is being Transformed by Increasing Demand for Generics

Generics play a vital role in improving healthcare access, particularly in developing countries where brand-name drugs can be costly. Many governments actively promote the use of generic drugs to reduce healthcare expenditures and enhance access to medications for their citizens. The aging global population increases the demand for medications for chronic conditions, with generic drugs often being prescribed for such cases. Growing middle-class populations in emerging economies drive increased healthcare expenditures, resulting in a higher demand for affordable medications. Governments and regulatory bodies have actively encouraged the use of generics and facilitated easier approval processes, further stimulating demand.

High Manufacturing Cost will Limit the Growth Potential

The high manufacturing cost associated with active pharmaceutical ingredients may hamper API market growth. The raw materials used are API-specific, so the quality of the raw material components used in the API development process is critical. Designing a new chemistry for each API project is tedious and complicated. Furthermore, the drug substance manufacturing process is a complex mechanism involving a wide range of chemical and biological processes. The API manufacturers often employ set regulations to determine the size and strength of an API in a certain medication. These factors drive the cost of API manufacturing processes and may hinder API market growth for the foreseeable future.

What Questions Should You Ask before Buying a Market Research Report?

• How is the Active Pharmaceutical Ingredients Market evolving?
• What is driving and restraining the Active Pharmaceutical Ingredients Market?
• How will each Active Pharmaceutical Ingredients submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Active Pharmaceutical Ingredients submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Active Pharmaceutical Ingredients Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Active Pharmaceutical Ingredients projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Active Pharmaceutical Ingredients projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Active Pharmaceutical Ingredients Market?
• Where is the Active Pharmaceutical Ingredients Market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Active Pharmaceutical Ingredients Market today, and over the next 10 years:

• Our 267-page report provides 98 tables and 167 charts/graphs exclusively to you
• The report highlights key lucrative areas in the industry so you can target them - NOW
• It contains in-depth analysis of global, regional and national sales and growth
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Active Pharmaceutical Ingredients Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
• You will find original analyses, with business outlooks and developments
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Active Pharmaceutical Ingredients prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Therapeutic Application

• Oncology
• Anti-diabetics
• Pulmonology
• Immuno-suppressants
• Neurology
• Cardiology
• Ophthalmology
• Orthopedic
• Others

Synthesis Type

• Synthetic
• Biotech

Manufacturer

• Merchant API
• Captive API

Drug Type

• Branded
• Generic

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America

• U.S
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

Leading companies profiled in the report:

Overall world revenue for Active Pharmaceutical Ingredients Market, 2023 to 2033 in terms of value the market will surpass US$235 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Active Pharmaceutical Ingredients Market, 2023 to 2033 report help you?

In summary, our 260+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Active Pharmaceutical Ingredients Market with forecasts for therapeutic application, synthesis type, manufacturer, and drug type, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 20 key national markets - See forecasts for the Active Pharmaceutical Ingredients Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Active Pharmaceutical Ingredients Market, 2023 to 2033

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Active Pharmaceutical Ingredients Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Active Pharmaceutical Ingredients Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report
• 1.6 Who is This Report for?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Reports
• 1.10 About

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
  • 3.2.1 Market Driving Factors
    • 3.2.1.1 Growing Prevalence of Chronic Diseases
    • 3.2.1.2 Rising Drug Research and Development Activities
    • 3.2.1.3 Increasing Demand for Generics
    • 3.2.1.4 Increasing Uptake of Biopharmaceuticals
  • 3.2.2 Market Restraining Factors
    • 3.2.2.1 Unfavourable Drug Price Control Policies
    • 3.2.2.2 High Manufacturing Costs
  • 3.2.3 Market Opportunities
    • 3.2.3.1 Increasing Demand for Specialty APIs
    • 3.2.3.2 Growing Preference for Personalized Medicines
• 3.3 COVID-19 Impact Analysis
• 3.4 Porter's Five Forces Analysis
  • 3.4.1 Bargaining Power of Suppliers
  • 3.4.2 Bargaining Power of Buyers
  • 3.4.3 Competitive Rivalry
  • 3.4.4 Threat from Substitutes
  • 3.4.5 Threat of New Entrants
• 3.5 PEST Analysis

4 Active Pharmaceutical Ingredients Market Analysis by Therapeutic Application

• 4.1 Key Findings
• 4.2 Therapeutic Application Segment: Market Attractiveness Index
• 4.3 Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
• 4.4 Oncology
  • 4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.4.2 Market Share by Region, 2023 & 2033 (%)
• 4.5 Anti-diabetics
  • 4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.5.2 Market Share by Region, 2023 & 2033 (%)
• 4.6 Pulmonology
  • 4.6.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.6.2 Market Share by Region, 2023 & 2033 (%)
• 4.7 Immuno-suppressants
  • 4.7.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.7.2 Market Share by Region, 2023 & 2033 (%)
• 4.8 Neurology
  • 4.8.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.8.2 Market Share by Region, 2023 & 2033 (%)
• 4.9 Cardiology
  • 4.9.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.9.2 Market Share by Region, 2023 & 2033 (%)
• 4.10 Ophthalmology
  • 4.10.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.10.2 Market Share by Region, 2023 & 2033 (%)
• 4.11 Orthopaedic
  • 4.11.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.11.2 Market Share by Region, 2023 & 2033 (%)
• 4.12 Others
  • 4.12.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.12.2 Market Share by Region, 2023 & 2033 (%)

5 Active Pharmaceutical Ingredients Market Analysis by Synthesis Type

• 5.1 Key Findings
• 5.2 Synthesis Type Segment: Market Attractiveness Index
• 5.3 Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
• 5.4 Synthetic
  • 5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 5.4.2 Market Share by Region, 2023 & 2033 (%)
• 5.5 Biotech
  • 5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 5.5.2 Market Share by Region, 2023 & 2033 (%)

6 Active Pharmaceutical Ingredients Market Analysis by Manufacturer

• 6.1 Key Findings
• 6.2 Manufacturer Segment: Market Attractiveness Index
• 6.3 Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
• 6.4 Merchant API
  • 6.4.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 6.4.2 Market Share by Region, 2023 & 2033 (%)
• 6.5 Captive API
  • 6.5.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 6.5.2 Market Share by Region, 2023 & 2033 (%)

7 Active Pharmaceutical Ingredients Market Analysis by Drug Type

• 7.1 Key Findings
• 7.2 Drug Type Segment: Market Attractiveness Index
• 7.3 Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
• 7.4 Branded
  • 7.4.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 7.4.2 Market Share by Region, 2023 & 2033 (%)
• 7.5 Generic
  • 7.5.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 7.5.2 Market Share by Region, 2023 & 2033 (%)

8 Active Pharmaceutical Ingredients Market Analysis by Region

• 8.1 Key Findings
• 8.2 Regional Market Size Estimation and Forecast

9 North America Active Pharmaceutical Ingredients Market Analysis

• 9.1 Key Findings
• 9.2 North America Active Pharmaceutical Ingredients Market Attractiveness Index
• 9.3 North America Active Pharmaceutical Ingredients Market by Country, 2023, 2028 & 2033 (US$ Billion)
• 9.4 North America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Country
• 9.5 North America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
• 9.6 North America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
• 9.7 North America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
• 9.8 North America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
• 9.9 U.S. Active Pharmaceutical Ingredients Market Analysis
• 9.10 Canada Active Pharmaceutical Ingredients Market Analysis

10 Europe Active Pharmaceutical Ingredients Market Analysis

• 10.1 Key Findings
• 10.2 Europe Active Pharmaceutical Ingredients Market Attractiveness Index
• 10.3 Europe Active Pharmaceutical Ingredients Market by Country, 2023, 2028 & 2033 (US$ Billion)
• 10.4 Europe Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Country
• 10.5 Europe Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
• 10.6 Europe Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
• 10.7 Europe Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
• 10.8 Europe Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
• 10.9 Germany Active Pharmaceutical Ingredients Market Analysis
• 10.10 France Active Pharmaceutical Ingredients Market Analysis
• 10.11 UK Active Pharmaceutical Ingredients Market Analysis
• 10.12 Italy Active Pharmaceutical Ingredients Market Analysis
• 10.13 Spain Active Pharmaceutical Ingredients Market Analysis
• 10.14 Russia Active Pharmaceutical Ingredients Market Analysis
• 10.15 Rest of Europe Active Pharmaceutical Ingredients Market Analysis

11 Asia Pacific Active Pharmaceutical Ingredients Market Analysis

• 11.1 Key Findings
• 11.2 Asia Pacific Active Pharmaceutical Ingredients Market Attractiveness Index
• 11.3 Asia Pacific Active Pharmaceutical Ingredients Market by Country, 2023, 2028 & 2033 (US$ Billion)
• 11.4 Asia Pacific Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Country
• 11.5 Asia Pacific Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
• 11.6 Asia Pacific Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
• 11.7 Asia Pacific Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
• 11.8 Asia Pacific Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
• 11.9 Japan Active Pharmaceutical Ingredients Market Analysis
• 11.10 China Active Pharmaceutical Ingredients Market Analysis
• 11.11 India Active Pharmaceutical Ingredients Market Analysis
• 11.12 Australia Active Pharmaceutical Ingredients Market Analysis
• 11.13 South Korea Active Pharmaceutical Ingredients Market Analysis
• 11.14 Rest of Asia Pacific Active Pharmaceutical Ingredients Market Analysis

12 Latin America Active Pharmaceutical Ingredients Market Analysis

• 12.1 Key Findings
• 12.2 Latin America Active Pharmaceutical Ingredients Market Attractiveness Index
• 12.3 Latin America Active Pharmaceutical Ingredients Market by Country, 2023, 2028 & 2033 (US$ Billion)
• 12.4 Latin America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Country
• 12.5 Latin America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
• 12.6 Latin America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
• 12.7 Latin America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
• 12.8 Latin America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
• 12.9 Brazil Active Pharmaceutical Ingredients Market Analysis
• 12.10 Mexico Active Pharmaceutical Ingredients Market Analysis
• 12.11 Rest of Latin America Active Pharmaceutical Ingredients Market Analysis

13 MEA Active Pharmaceutical Ingredients Market Analysis

• 13.1 Key Findings
• 13.2 MEA Active Pharmaceutical Ingredients Market Attractiveness Index
• 13.3 MEA Active Pharmaceutical Ingredients Market by Country, 2023, 2028 & 2033 (US$ Billion)
• 13.4 MEA Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Country
• 13.5 MEA Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
• 13.6 MEA Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
• 13.7 MEA Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
• 13.8 MEA Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
• 13.9 GCC Active Pharmaceutical Ingredients Market Analysis
• 13.10 South Africa Active Pharmaceutical Ingredients Market Analysis
• 13.11 Rest of MEA Active Pharmaceutical Ingredients Market Analysis

14 Company Profiles

• 14.1 Competitive Landscape, 2022
• 14.2 Strategic Outlook
• 14.3 Aarti Drugs Ltd.
  • 14.3.1 Company Snapshot
  • 14.3.2 Company Overview
  • 14.3.3 Financial Analysis
    • 14.3.3.1 Net Revenue, 2017-2022
    • 14.3.3.2 R&D, 2017-2022
    • 14.3.3.3 Regional Market Shares, 2022
  • 14.3.4 Product Benchmarking
• 14.4 Aurobindo Pharma
  • 14.4.1 Company Snapshot
  • 14.4.2 Company Overview
  • 14.4.3 Financial Analysis
    • 14.4.3.1 Net Revenue, 2017-2022
    • 14.4.3.2 R&D, 2017-2022
    • 14.4.3.3 Regional Market Shares, 2022
  • 14.4.4 Product Benchmarking
• 14.5 Biocon
  • 14.5.1 Company Snapshot
  • 14.5.2 Company Overview
  • 14.5.3 Financial Analysis
    • 14.5.3.1 Net Revenue, 2017-2022
    • 14.5.3.2 R&D, 2017-2022
    • 14.5.3.3 Regional Market Shares, 2022
  • 14.5.4 Product Benchmarking
  • 14.5.5 Strategic Outlook
• 14.6 Cipla Inc.
  • 14.6.1 Company Snapshot
  • 14.6.2 Company Overview
  • 14.6.3 Financial Analysis
    • 14.6.3.1 Net Revenue, 2017-2022
    • 14.6.3.2 R&D, 2017-2022
    • 14.6.3.3 Regional Market Shares, 2022
  • 14.6.4 Product Benchmarking
  • 14.6.5 Strategic Outlook
• 14.7 Divi's Laboratories Limited
  • 14.7.1 Company Snapshot
  • 14.7.2 Company Overviews
  • 14.7.3 Financial Analysis
    • 14.7.3.1 Net Revenue, 2017-2022
    • 14.7.3.2 R&D, 2017-2022
    • 14.7.3.3 Regional Market Shares, 2022
  • 14.7.4 Product Benchmarking
• 14.8 Dr. Reddy's Laboratories Ltd.
  • 14.8.1 Company Snapshot
  • 14.8.2 Company Overview
  • 14.8.3 Financial Analysis
    • 14.8.3.1 Net Revenue, 2017-2022
    • 14.8.3.2 R&D, 2017-2022
    • 14.8.3.3 Regional Market Shares, 2022
  • 14.8.4 Product Benchmarking
  • 14.8.5 Strategic Outlook
• 14.9 EUROAPI
  • 14.9.1 Company Snapshot
  • 14.9.2 Company Overview
  • 14.9.3 Financial Analysis
    • 14.9.3.1 Net Revenue, 2017-2022
    • 14.9.3.2 R&D, 2017-2022
  • 14.9.4 Product Benchmarking
  • 14.9.5 Strategic Outlook
• 14.10 HIKAL Ltd.
  • 14.10.1 Company Snapshot
  • 14.10.2 Company Overview
  • 14.10.3 Financial Analysis
    • 14.10.3.1 Net Revenue, 2017-2022
    • 14.10.3.2 R&D, 2017-2022
  • 14.10.4 Product Benchmarking
  • 14.10.5 Strategic Outlook
• 14.11 Merck & Co., Inc.
  • 14.11.1 Company Snapshot
  • 14.11.2 Company Overview
  • 14.11.3 Financial Analysis
    • 14.11.3.1 Net Revenue, 2017-2022
    • 14.11.3.2 R&D, 2017-2022
    • 14.11.3.3 Regional Market Shares, 2022
  • 14.11.4 Product Benchmarking
  • 14.11.5 Strategic Outlook
• 14.12 Teva Pharmaceutical Industries Ltd.
  • 14.12.1 Company Snapshot
  • 14.12.2 Company Overview
  • 14.12.3 Financial Analysis
    • 14.12.3.1 Net Revenue, 2017-2022
    • 14.12.3.2 R&D, 2017-2022
    • 14.12.3.3 Regional Market Shares, 2022
  • 14.12.4 Product Benchmarking

15 Conclusion and Recommendations

• 15.1 Concluding Remarks from
• 15.2 Recommendations for Market Players